Further studies demonstrated that PVT1 enhances the proliferation and migration ability of bladder cancer cells by directly interacting with miR-128, increasing the expression of vascular endothelial growth factor C (VEGF-C), a target of miR-128 that functions as a lymphatic vascular system growth factor [44]. The gene discussed is VEGFC; the disease is urinary bladder carcinoma.